http://utenportugal.org/2009/02/biotech-the-impossible-dream/ Professionalizing and Advancing S&T Commercialization in Portugal Thu, 22 Apr 2010 17:00:33 +0000 hourly 1 http://wordpress.org/?v=3.2.1 http://utenportugal.org/2009/02/biotech-the-impossible-dream/comment-page-1/#comment-31 Tom Gardner Tue, 10 Feb 2009 09:26:18 +0000 http://utenportugal.org/?p=508#comment-31 I agree Luis, the more I see and understand about the PT business landscape the more I believe it is a greater obstacle than in the US, but I feel it is important to note that the landscape in the US was extremely difficult in the 1960's - 1980's as the larger Pharma players dominated the industry even more so than they do now. This changed because of many reasons - the most important being, in my opinion - the government looked at how to assist smaller companies in an increasingly harsh regulatory landscape. So this would lead me to believe that PT could provide the same assistance. The question then becomes can PT's private sector provide the financing and the support to create the PT's equivalent of Genentech, Eli-Lilly or Alcon. I agree Luis, the more I see and understand about the PT business landscape the more I believe it is a greater obstacle than in the US, but I feel it is important to note that the landscape in the US was extremely difficult in the 1960′s – 1980′s as the larger Pharma players dominated the industry even more so than they do now. This changed because of many reasons – the most important being, in my opinion – the government looked at how to assist smaller companies in an increasingly harsh regulatory landscape. So this would lead me to believe that PT could provide the same assistance. The question then becomes can PT’s private sector provide the financing and the support to create the PT’s equivalent of Genentech, Eli-Lilly or Alcon.

]]> http://utenportugal.org/2009/02/biotech-the-impossible-dream/comment-page-1/#comment-27 Luis Amado Mon, 09 Feb 2009 22:08:22 +0000 http://utenportugal.org/?p=508#comment-27 I agree the key issue is not the IP or technology, therefore you can start a company without having any of these. The disadvantage is that it would even take you some more years and consequently euros or ; the advantage is the you would, in principle, base it in an technology /IP adequate to market needs. I guess it is true that management is key but sometimes, specially in harder times and landscapes (I consider PT a hard landscape for biotech) that is not enough you also need to be strong in other areas. I agree the key issue is not the IP or technology, therefore you can start a company without having any of these. The disadvantage is that it would even take you some more years and consequently euros or ; the advantage is the you would, in principle, base it in an technology /IP adequate to market needs.
I guess it is true that management is key but sometimes, specially in harder times and landscapes (I consider PT a hard landscape for biotech) that is not enough you also need to be strong in other areas.

]]>